Doxorubicin And Cyclophosphamide Followed By Weekly Docetaxel As Neoadjuvant Treatment Of Early Breast Cancer: Analysis Of Biological Markers In A GEICAM Phase II Study
Laura G. Estevez, José Luis Fortes, Encarna Adrover, Gloria Peiró, Mireia Margelí, Eva Castellá, José Miguel Cuevas, Laia Bernet, Miguel Angel Segui, Xavier Andreu,
Twitter
Facebook
LinkedIn
Email